Abstract
The contribution of diet to the development of several chronic diseases, such as vascular disease, diabetes or lipid abnormalities has been established. Therefore, clinical trials dealing with these diseases need to adjust for individual dietary habits in order to account for potential confounding. Common practice in the majority of studies that collect dietary information is to record individual habits using specific questionnaires (e.g. Food Frequency questionnaires, FFQ). Nevertheless, a major challenge in nutrition assessment is the correct measurement of dietary exposure. This can be expressed as the reliability and validity of the retrieved information. These issues refer to how close the food records and the energy intake estimated by a tool represent actual food intake. To establish accuracy of a tool is of major importance in order to avoid inconsistent estimates of dietary intake that can distort any potential relation between diet, pharmacological treatment and disease. The aim of this review is to critically present commonly used statistical methods in reliability and validity studies.
Keywords: Reliability, validity, repeatability, accuracy, dietary assessment, clinical trials, Nutraceuticals and Chronic Illness, Nutrition Assessment, questionnaires (FFQ), memory lapses, Inter-rater reliability, Test-retest, Inter-method reliability, Internal consistency reliabil-ity, Correlation Coefficients, Spearman's rho correlation coefficient, Pearson's correlation coefficient, The intra-class correlation coefficient, Spearman-Brown reliability coefficient, Cronbach's Alpha, Kendall's Tau, Cohen's Kappa, The Bland and Altman Method, limits of agreement, fanning, Paired Comparisons
Current Pharmaceutical Design
Title: Statistical Methods Used for the Evaluation of Reliability and Validity of Nutrition Assessment Tools Used in Medical Research
Volume: 16 Issue: 34
Author(s): Vassiliki Bountziouka and Demosthenes B. Panagiotakos
Affiliation:
Keywords: Reliability, validity, repeatability, accuracy, dietary assessment, clinical trials, Nutraceuticals and Chronic Illness, Nutrition Assessment, questionnaires (FFQ), memory lapses, Inter-rater reliability, Test-retest, Inter-method reliability, Internal consistency reliabil-ity, Correlation Coefficients, Spearman's rho correlation coefficient, Pearson's correlation coefficient, The intra-class correlation coefficient, Spearman-Brown reliability coefficient, Cronbach's Alpha, Kendall's Tau, Cohen's Kappa, The Bland and Altman Method, limits of agreement, fanning, Paired Comparisons
Abstract: The contribution of diet to the development of several chronic diseases, such as vascular disease, diabetes or lipid abnormalities has been established. Therefore, clinical trials dealing with these diseases need to adjust for individual dietary habits in order to account for potential confounding. Common practice in the majority of studies that collect dietary information is to record individual habits using specific questionnaires (e.g. Food Frequency questionnaires, FFQ). Nevertheless, a major challenge in nutrition assessment is the correct measurement of dietary exposure. This can be expressed as the reliability and validity of the retrieved information. These issues refer to how close the food records and the energy intake estimated by a tool represent actual food intake. To establish accuracy of a tool is of major importance in order to avoid inconsistent estimates of dietary intake that can distort any potential relation between diet, pharmacological treatment and disease. The aim of this review is to critically present commonly used statistical methods in reliability and validity studies.
Export Options
About this article
Cite this article as:
Bountziouka Vassiliki and B. Panagiotakos Demosthenes, Statistical Methods Used for the Evaluation of Reliability and Validity of Nutrition Assessment Tools Used in Medical Research, Current Pharmaceutical Design 2010; 16 (34) . https://dx.doi.org/10.2174/138161210794455102
DOI https://dx.doi.org/10.2174/138161210794455102 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Rheumatoid Arthritis: Notable Biomarkers Linking to Chronic Systemic Conditions and Cancer
Current Pharmaceutical Design Vitamin D and Stroke: Promise for Prevention and Better Outcome
Current Vascular Pharmacology Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not A
Current Vascular Pharmacology Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets All for Statins and Statins for All; An Update
Current Pharmaceutical Design Inflammatory and Oxidative Stress Markers as Indicator of Atherogenesis in Rats: Antioxidants as Preventive Pharmacological Methods
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?
Inflammation & Allergy - Drug Targets (Discontinued) Reduction in Vascular Endothelial Growth Factor Expression in the Superior Temporal, Hippocampal, and Brainstem Regions in Alzheimer`s Disease
Current Neurovascular Research Interstitial Lung Disease in Sjogrens Syndrome
Current Rheumatology Reviews The Role of AGEs in Cardiovascular Disease
Current Pharmaceutical Design Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis
Current Pharmaceutical Design Pharmacological Intervention in Type 2 Diabetes Mellitus – A Pathophysiologically Reasoned Approach?
Current Diabetes Reviews Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Current Vascular Pharmacology Editorial (Hot Topic: Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular Damage)
Current Pharmaceutical Design Lower Financial Status and Adherence to Medication Determines 10-Year (2004-2014) All-Cause Mortality and Risk for Acute Coronary Syndrome Incidence Among Cardiac Patients: the GREECS Study
Current Vascular Pharmacology Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Novel Oral Anticoagulants: Recommendations for Patient Evaluation, Treatment Initiation, Follow-up and Perioperative Management
Cardiovascular & Hematological Disorders-Drug Targets Potential Impact of Genetic Variants in Nrf2 Regulated Antioxidant Genes and Risk Prediction of Diabetes and Associated Cardiac Complications
Current Medicinal Chemistry Aminoacid Support in the Prevention of Diabetes and Diabetic Complications
Current Protein & Peptide Science